GSK Expands Collaboration to Deploy Cellular Model MORGAN in $110M Deal
chaitjo · x · 2026-08-01
Biotech company Relation Therapeutics announced an expanded collaboration with pharmaceutical giant GSK to deploy MORGAN, its flagship cellular foundation model. The deal will bring up to $110 million in upfront and success-based milestone payments, signaling strong industry validation for AI-driven drug discovery.
Related event: Relation and GSK Expand AI Drug Discovery Partnership to $110M(2 posts)→
More from Venture
- a16z: AI Infra Demand Surges, but Supply Chain Bottlenecks Delay Deliveries — a16z · 2026-08-01
- Leopold's Letter to LPs: Fund Plunged 67% in July but Up 80% YTD — PTrubey · 2026-08-01
- OpenAI Price Cuts Unlock a New Class of Viable AI Products — JonathanRoss321 · 2026-08-01
- AI Market Correction Warning: Extreme Leverage in Memory Chips and Record Investor Debt — binarybits · 2026-08-01
- MediaTek Targets $12-16B Data Center Revenue by 2027, TPU v8t to Exceed $2B — BenBajarin · 2026-08-01
- Hedge Funder Mocks Leopold's AGI Investment Strategy — JOBhakdi · 2026-08-01